Effect of FTY720 on the SET-PP2A complex in acute myeloid leukemia; SET binding drugs have antagonistic activity

被引：58
|
作者：
Pippa, R. [1 ]
Dominguez, A. [1 ]
Christensen, D. J. [2 ]
Moreno-Miralles, I. [1 ]
Blanco-Prieto, M. J. [3 ]
Vitek, M. P. [2 ]
Odero, M. D. [1 ,4 ]
机构：
[1] Univ Navarra, Ctr Appl Med Res CIMA, Hematol Oncol Program, Navarra, Spain
[2] Oncotide Pharmaceut, Res Triangle Pk, NC USA
[3] Univ Navarra, Sch Pharm, Dept Pharm & Pharmaceut Technol, Navarra, Spain
[4] Univ Navarra, Dept Biochem & Genet, Navarra, Spain
来源：
LEUKEMIA | 2014年 / 28卷 / 09期
关键词：
PROTEIN PHOSPHATASE 2A; INHIBITION; I-2(PP2A)/SET; ACTIVATION; EFFICACY; THERAPY; EVENT;
D O I：
10.1038/leu.2014.141
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1915 / 1918
页数：4
相关论文
共 23 条
  • [1] EFFECT OF FTY720 ON THE SET-PP2A COMPLEX IN ACUTE MYELOID LEUKEMIA. SET BINDING DRUGS HAVE ANTAGONISTIC ACTIVITY
    Pippa, R.
    Dominguez, A.
    Christensen, D. J.
    Moreno-Miralles, I.
    Blanco-Prieto, M.
    Bachs, O.
    Ye, K.
    Vitek, M. P.
    Odero, M. D.
    HAEMATOLOGICA, 2014, 99 : 796 - 796
  • [2] Effect of FTY720 on the SET–PP2A complex in acute myeloid leukemia; SET binding drugs have antagonistic activity
    R Pippa
    A Dominguez
    D J Christensen
    I Moreno-Miralles
    M J Blanco-Prieto
    M P Vitek
    M D Odero
    Leukemia, 2014, 28 : 1915 - 1918
  • [3] A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicity
    Vicente, Carmen
    Arriazu, Elena
    Martinez-Balsalobre, Elena
    Peris, Irene
    Marcotegui, Nerea
    Garcia-Ramirez, Patricia
    Pippa, Raffaella
    Rabal, Obdulia
    Oyarzabal, Julen
    Guruceaga, Elizabeth
    Prosper, Felipe
    Mateos, Maria C.
    Cayuela, Maria L.
    Odero, Maria D.
    CANCER LETTERS, 2020, 468 : 1 - 13
  • [4] The NMR-based characterization of the FTY720-SET complex reveals an alternative mechanism for the attenuation of the inhibitory SET-PP2A interaction
    De Palma, Ryan M.
    Parnham, Stuart R.
    Lo, Yitong
    Oaks, Joshua J.
    Peterson, Yuri K.
    Szulc, Zdzislaw M.
    Roth, Braden M.
    Xing, Yongna
    Ogretmen, Besim
    FASEB JOURNAL, 2019, 33 (06): : 7647 - 7666
  • [5] Pharmacologic Restoration of PP2A Activity and Interference with the SET-PP2A Interplay by FTY720 and Its Non-Immunosuppressive Derivative as a Novel and Efficient Therapy for Ph-Negative Myeloproliferative Disorders
    Oaks, Joshua J.
    Mukhopadhyay, A.
    Santhanam, Ramasamy
    Saddoughi, S. A.
    Walker, Christopher
    Neviani, Paolo
    Harb, Jason G.
    Ma, Y.
    Verstovsek, Srdan
    Marcucci, Guido
    Briesewitz, Roger
    Bittman, Robert
    Chen, Ching-Shih
    Quintas-Cardama, Alfonso
    Ogretmen, Besim
    Perrotti, Danilo
    BLOOD, 2010, 116 (21) : 340 - 340
  • [6] THE COMBINATION OF VENETOCLAX AND FTY720 HAS A SYNERGISTIC PRO-APOPTOTIC EFFECT IN ACUTE MYELOID LEUKEMIA
    Irene, Peris
    Elena, Martinez-Balsalobre
    Elena, Arriazu
    Silvia, Romero-Murillo
    Javier, Marco
    Nerea, Marcotegui
    Andrea, Torres-Lopez
    Carmen, Mateos M.
    Luisa, Cayuela M.
    Dolores, Odero M.
    Carmen, Vicente
    HAEMATOLOGICA, 2020, 105 : 53 - 54
  • [7] CM942 IS A NEW SMALL MOLECULE THAT TARGETS SET-PP2A INTERACTION AND INHIBITS GROWTH OF ACUTE MYELOID LEUKEMIA CELLS
    Garcia-Ramirez, P.
    Vicente, C.
    Arriazu, E.
    Nerea, M.
    Rifon, J.
    Dominguez, A.
    Alonso, A.
    Vazquez, I.
    Calasanz, M. J.
    Mateos, M. C.
    Odero, M. D.
    HAEMATOLOGICA, 2017, 102 : 50 - 50
  • [8] Targeting SET-PP2A complex as a new avenue of treatment for Mixed Lineage Leukemia (MLL) treatment
    Di Mambro, A.
    Arroyo-Berdugo, Y.
    Calle, Y.
    Wrench, B.
    Gribben, J.
    Esposito, M. T.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 51 - 52
  • [9] Reactivating PP2A by FTY720-Loaded Lipid Nanoparticles, a Novel Therapeutic Strategy in Acute Myeloid Leukemia
    Estella-Hermoso de Mendoza, Ander
    Castello-Cros, Remedios
    Cirauqui, Cristina
    Pippa, Raffaella
    Moreno, Isabel
    Blanco-Prieto, Maria J.
    Odero, Maria D.
    BLOOD, 2012, 120 (21)
  • [10] P38B MAPK INTERACTS WITH SET REGULATING ITS INHIBITORY EFFECT ON PP2A ACTIVITY IN ACUTE MYELOID LEUKEMIA
    Arriazu, E.
    Vicente, C.
    Pippa, R.
    Marcotegui, N.
    Igea, A.
    Leon, E.
    Chocarro, S.
    Soto, M.
    Nebreda, A. R.
    Odero, M. D.
    HAEMATOLOGICA, 2017, 102 : 205 - 205
123